Lvnan Yan

机构：Sichuan University, West China Hospital of Sichuan University, Pulmonary and Critical Care Associates · ORCID：0000-0003-1371-8903

发表论文 108 篇 · 总被引 2935 次 · h-index 25

代表论文

• Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 270)
• HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma (2022 · Redox Biology · 被引 91)
• The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition (2022 · Cancer Letters · 被引 55)
• Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis (2019 · PLoS ONE · 被引 29)
• A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma (2019 · PLoS ONE · 被引 23)
• Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma (2019 · Medicine · 被引 23)